Kenneth M Kaye

Title: Innovations by Kenneth M Kaye

Introduction

Kenneth M Kaye is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of molecular biology, particularly in understanding the mechanisms of viral persistence.

Latest Patents

Kenneth M Kaye holds 3 patents, with his latest inventions focusing on assays for compounds that modulate rhadino virus LANA action. His work explores the role of the latency-associated nuclear antigen (LANA) in primary effusion lymphoma (PEL) cells, which harbor Kaposi's sarcoma-associated herpesvirus (KSHV) episomes. Kaye's research demonstrates how LANA and KSHV DNA co-localize in interphase nuclei and along mitotic chromosomes, highlighting the importance of LANA in the persistence of episomes containing specific KSHV DNA fragments. His findings support a model where LANA tethers episomes to chromosomes during mitosis, facilitating efficient segregation to progeny cells. The methods and products of his inventions are valuable for identifying compounds that modulate the persistence of rhadino virus DNA in mammalian cells, which has implications for gene therapies.

Career Highlights

Throughout his career, Kenneth M Kaye has focused on innovative research that bridges the gap between virology and therapeutic applications. His work has contributed to a deeper understanding of viral mechanisms and their potential modulation for therapeutic purposes.

Collaborations

Kenneth has collaborated with esteemed colleagues such as Elliott D Kieff and Mary E Ballestas, further enhancing the impact of his research through shared expertise and insights.

Conclusion

Kenneth M Kaye's innovative work in the field of molecular biology and virology has led to significant advancements in understanding viral persistence and its modulation. His contributions continue to influence research and therapeutic strategies in the medical field.